Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Changing Diabetes® World Tour Novonordisk Ongoing N/A 4 version 6 - October 2010 King Abdulaziz University Hospital (Jeddah)
An observational study to evaluate caregiver's preference and treatment outcome in patient with alzheimer's disease treated with oral or tramsdermal monotheraby - Real-World Evaluation of compliance and preference in the treatment of Alzheimer's disease(RECAP). Novartis Ongoing Rivastigmine 4 CENA713D-MAX-SA-01 Dr. Soliman Fakeeh Hospital (Jeddah)
DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 AstraZeneca Ongoing N/A 4 D1690R0000 King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah)
A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors Novonordisk Ongoing NovoSeven (activated recombinant factor VII) 4 F7HEAM-3850 King Khalid University Hospital (Riyadh)
A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia Tabuk Pharmaceuticals Ongoing NERVAX 4 N-001 King Fahad Medical City (Riyadh)
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients Sanofi Ongoing N/A 4 2 King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment Sanofi Ongoing N/A 4 OBS13780 King Khalid University Hospital (Riyadh)
A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia Tabuk Pharmaceuticals Ongoing Divido 4 D-001 King Fahad Medical City (Riyadh)
Verifying Insulin Strategy and Initial Health Outcome Analysi Eli Lilly Ongoing N/A 4 F3Z-MC-B01 International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study ) AstraZeneca Ongoing N/A 4 RME-XXX-20 Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
View 681 - 690 From 799